Cargando…

Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study

BACKGROUND: Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle mass and function and has a negative impact on clinical outcomes associated with chronic obstructive pulmonary disease (COPD). Recently, the sarcopenia index (SI) was developed as a surrogate marker of sarcopenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xuanna, Su, Ruoxin, Hu, Rongwei, Chen, Yujuan, Xu, Xiaoyong, Yuan, Yalian, Zhang, Jinhong, Zhang, Wenchao, Yang, Yu, Chen, Min, Li, Dongming, Wu, Bin, Huang, Dan, Wu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921248/
https://www.ncbi.nlm.nih.gov/pubmed/36774462
http://dx.doi.org/10.1186/s12877-023-03784-7
_version_ 1784887266679717888
author Zhao, Xuanna
Su, Ruoxin
Hu, Rongwei
Chen, Yujuan
Xu, Xiaoyong
Yuan, Yalian
Zhang, Jinhong
Zhang, Wenchao
Yang, Yu
Chen, Min
Li, Dongming
Wu, Bin
Huang, Dan
Wu, Dong
author_facet Zhao, Xuanna
Su, Ruoxin
Hu, Rongwei
Chen, Yujuan
Xu, Xiaoyong
Yuan, Yalian
Zhang, Jinhong
Zhang, Wenchao
Yang, Yu
Chen, Min
Li, Dongming
Wu, Bin
Huang, Dan
Wu, Dong
author_sort Zhao, Xuanna
collection PubMed
description BACKGROUND: Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle mass and function and has a negative impact on clinical outcomes associated with chronic obstructive pulmonary disease (COPD). Recently, the sarcopenia index (SI) was developed as a surrogate marker of sarcopenia based upon the serum creatinine to cystatin C ratio. We aimed to assess the value of SI for predicting clinically important outcomes among elderly patients with acute exacerbation of COPD (AECOPD). METHODS: This cross-sectional study included elderly patients with AECOPD in China from 2017 to 2021. Clinical data were collected from medical records, and serum creatinine and cystatin C were measured. Outcomes included respiratory failure, heart failure, severe pneumonia, invasive mechanical ventilation, and mortality. Binary logistic regression was used to analyze the association between SI and clinical outcomes. RESULTS: A total of 306 patients (260 men, 46 women, age range 60–88 years) were enrolled in this study. Among the total patients, the incidence of respiratory failure and severe pneumonia was negatively associated with SI values. After adjusting for potential confounding factors, binary logistic regression analyses showed that a higher SI was still independently associated with a lower risk of respiratory failure (odds ratio [OR]: 0.27, 95% confidence interval [CI]: 0.13–0.56, P < 0.05). In subgroup analysis, the incidence of respiratory failure was negatively associated with SI values in groups with both frequent exacerbation and non-frequent exacerbation. After adjustment for potential confounders, binary logistic regression analyses showed that a higher SI was also independently associated with a lower risk of respiratory failure in both groups (OR: 0.19, 95% CI: 0.06–0.64 and OR: 0.31, 95% CI: 0.11–0.85). However, there were no significant differences in the correlations between SI and the risk of heart failure, invasive mechanical ventilation, and mortality in all groups. CONCLUSION: The SI based on serum creatinine and cystatin C can predict respiratory failure in patients with AECOPD and either frequent or infrequent exacerbations. This indicator provides a convenient tool for clinicians when managing patients with AECOPD in daily clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03784-7.
format Online
Article
Text
id pubmed-9921248
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99212482023-02-12 Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study Zhao, Xuanna Su, Ruoxin Hu, Rongwei Chen, Yujuan Xu, Xiaoyong Yuan, Yalian Zhang, Jinhong Zhang, Wenchao Yang, Yu Chen, Min Li, Dongming Wu, Bin Huang, Dan Wu, Dong BMC Geriatr Research BACKGROUND: Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle mass and function and has a negative impact on clinical outcomes associated with chronic obstructive pulmonary disease (COPD). Recently, the sarcopenia index (SI) was developed as a surrogate marker of sarcopenia based upon the serum creatinine to cystatin C ratio. We aimed to assess the value of SI for predicting clinically important outcomes among elderly patients with acute exacerbation of COPD (AECOPD). METHODS: This cross-sectional study included elderly patients with AECOPD in China from 2017 to 2021. Clinical data were collected from medical records, and serum creatinine and cystatin C were measured. Outcomes included respiratory failure, heart failure, severe pneumonia, invasive mechanical ventilation, and mortality. Binary logistic regression was used to analyze the association between SI and clinical outcomes. RESULTS: A total of 306 patients (260 men, 46 women, age range 60–88 years) were enrolled in this study. Among the total patients, the incidence of respiratory failure and severe pneumonia was negatively associated with SI values. After adjusting for potential confounding factors, binary logistic regression analyses showed that a higher SI was still independently associated with a lower risk of respiratory failure (odds ratio [OR]: 0.27, 95% confidence interval [CI]: 0.13–0.56, P < 0.05). In subgroup analysis, the incidence of respiratory failure was negatively associated with SI values in groups with both frequent exacerbation and non-frequent exacerbation. After adjustment for potential confounders, binary logistic regression analyses showed that a higher SI was also independently associated with a lower risk of respiratory failure in both groups (OR: 0.19, 95% CI: 0.06–0.64 and OR: 0.31, 95% CI: 0.11–0.85). However, there were no significant differences in the correlations between SI and the risk of heart failure, invasive mechanical ventilation, and mortality in all groups. CONCLUSION: The SI based on serum creatinine and cystatin C can predict respiratory failure in patients with AECOPD and either frequent or infrequent exacerbations. This indicator provides a convenient tool for clinicians when managing patients with AECOPD in daily clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03784-7. BioMed Central 2023-02-11 /pmc/articles/PMC9921248/ /pubmed/36774462 http://dx.doi.org/10.1186/s12877-023-03784-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Xuanna
Su, Ruoxin
Hu, Rongwei
Chen, Yujuan
Xu, Xiaoyong
Yuan, Yalian
Zhang, Jinhong
Zhang, Wenchao
Yang, Yu
Chen, Min
Li, Dongming
Wu, Bin
Huang, Dan
Wu, Dong
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title_full Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title_fullStr Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title_full_unstemmed Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title_short Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
title_sort sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921248/
https://www.ncbi.nlm.nih.gov/pubmed/36774462
http://dx.doi.org/10.1186/s12877-023-03784-7
work_keys_str_mv AT zhaoxuanna sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT suruoxin sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT hurongwei sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT chenyujuan sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT xuxiaoyong sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT yuanyalian sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT zhangjinhong sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT zhangwenchao sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT yangyu sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT chenmin sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT lidongming sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT wubin sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT huangdan sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy
AT wudong sarcopeniaindexasapredictorofclinicaloutcomesamongolderadultpatientswithacuteexacerbationofchronicobstructivepulmonarydiseaseacrosssectionalstudy